William Blair Upgrades Achillion (ACHN) to Outperform; Janssen Deal Makes 'Tremendous Sense', D Program Has Potential, Says Analyst
Tweet Send to a Friend
(Updated - May 20, 2015 9:07 AM EDT)William Blair upgraded Achillion Pharmaceuticals (NASDAQ: ACHN) from Market Perform to Outperform and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
